pro-040201
Nucleic acidexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2009 (NCT00927459)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Apolipoprotein B-100INHIBITOR
APOB inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- pro-040201
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00927459 | Phase 1 | Jun 1, 2009 | Arbutus Biopharma Corporation, Medpace, Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Arbutus Biopharma Corporation | For profit | 1 | 1 | 1 | 2009 |
| Medpace, Inc. | For profit | 1 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1